Carbon dioxide (CO2) is one of the major greenhouse gases causing global warming. If carbon dioxide could be converted into energy, it would be killing two birds with one stone in addressing the environmental issues. A new photocatalyst is developed recently, which can produce methane fuel (CH4) selectively and effectively from carbon dioxide using sunlight. According to this research, the quantity of methane produced was almost doubled in the first 8 hours of the reaction process.
The research was conducted collaboratively by Australia, Malaysia, and the United Kingdom.
Inspired by the photosynthesis in nature, carbon dioxide can now be converted effectively into methane fuel by the newly designed solar-powered catalyst, which will lower carbon emission. Furthermore, this new catalyst is made from copper-based materials, which is abundant and hence affordable.
It is found that cuprous oxide (Cu2O), a semiconducting material, has been applied as both photocatalyst and electrocatalyst to reduce carbon dioxide into other chemical products like carbon monoxide and methane in different studies. However, it faces several limitations in the reduction process, including its inferior stability and the non-selective reduction which causes the formation of an array of various products. Separation and purification of these products from the mixture can be highly challenging and this imposes technological barrier for large scale application. Furthermore, cuprous oxide can be easily corroded after brief illumination and evolve into metallic copper or copper oxide.
To overcome these challenges, a novel photocatalyst is synthesized by enwrapping cuprous oxide with copper-based metal-organic frameworks (MOFs). Using this new catalyst, pure methane gas can selectively be produced. When compared with cuprous oxide without MOF shell, cuprous oxide with MOF shell reduced carbon dioxide into methane stably under visible-light irradiation with an almost doubled yield. Also, cuprous oxide with MOF shell was more durable and the maximum carbon dioxide uptake was almost seven times of the bare cuprous oxide.
Moreover, the research team discovered that the cuprous oxide was stabilized by the conformal coating of MOF. The excited charges in cuprous oxide upon illumination could efficiently migrate to the MOF. In this way, excessive accumulation of excited charges within the catalyst, which could lead to self-corrosion, was avoided. Hence extended the catalyst’s lifetime. The next step will be to further increase the methane production rate and explore ways to scale up both the synthesis of the catalyst and the reactor systems. In the entire process of converting carbon dioxide to methane, the only energy input we have used was sunlight. We hope in the future, carbon dioxide emitted from factories and transportation can be ‘recycled’ to produce alternate fuels.
Reference: Angewandte Chemie, titled “Metal-Organic Frameworks Decorated Cuprous Oxide Nanowires for Long-lived Charges Applied in Selective Photocatalytic CO2 Reduction to CH4”
In January 2025, the US FDA published a draft regulatory guidance entitled “The Considerations for Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products”.
The adoption of artificial intelligence (AI) and large language models (LLMs) is rapidly reshaping clinical research and drug development.
In the quest for increased sustainability, a lot has been made of the potential to use bio-based raw materials, captured CO2 and recycled plastics as raw materials for new chemicals. But what about using biotech processes to manufacture chemicals? Could it offer a more sustainable alternative to traditional petrochemical processing, and be more amenable to biobased raw materials?
High duties on imports from Canada, Mexico and China raise problems for international supply chains.
Advanced Drug Delivery Systems Market, valued at USD 234.84 billion in 2023, is on a trajectory of significant growth, projected to reach USD 352.01 billion by 2032
The U.S. Food and Drug Administration on January 15, 2025, announced its decision to ban Red Dye No. 3 also referred to as Erythrosine.
Targeted drug delivery revolutionises treatment by focusing medications on specific tissues, reducing the impact on healthy cells. Scientists enhance this precision with carriers like microspheres and nanoparticles, controlling release and absorption. Microspheres, made from biodegradable proteins or polymers, sustain drug release, making them ideal for targeted therapies, especially in oncology. Beyond drug delivery, microspheres open new possibilities across industries—from next-gen coatings to thermal insulation. With tailored sizes, shapes, and materials, they drive advancements in pharmaceuticals, advanced materials, and more.
The U.S. Food and Drug Administration (FDA) has proposed a new rule to require standardized testing of talc-containing cosmetics for asbestos. The FDA noted that this move aims to protect consumers from potential harm posed by asbestos, a known carcinogen linked to serious illnesses such as lung and ovarian cancers.
As one of the most significant holidays in China, Chinese New Year (CNY) profoundly impacts global shipping, logistics, and supply chains. Scheduled to begin on January 29, 2025, this festive period lasts up to two weeks, with many factories, ports, and businesses shutting down or operating with limited staff. Understanding the implications of CNY on your supply chain is critical to avoid disruptions and ensure seamless operations.